Neuroscience Research Center, Shahid Beheshti University of Medical Science, Tehran, Iran.
Department of Pharmacology, Shahid Beheshti University of Medical Science, Tehran, Iran.
Exp Gerontol. 2022 Jul;164:111812. doi: 10.1016/j.exger.2022.111812. Epub 2022 Apr 25.
Substantial evidence indicates that imbalance in the expression of miR-132-3p, miR-181b-5p, miR-125b-5p, miR-26a-5p, miR-124-3p, miR-146a-5p, miR-29a-3p, and miR-30a-5p in the AD brain are associated with amyloid-beta (Aβ) aggregation, tau pathology, neuroinflammation, and synaptic dysfunction, the major pathological hallmarks of Alzheimer's disease)AD(. Several studies have reported that intranasal insulin administration ameliorates memory in AD patients and animal models. However, the underlying molecular mechanisms are not yet completely elucidated. Therefore, the aim of this study was to determine whether insulin is involved in regulating the expression of AD-related microRNAs. Pursuing this objective, we first investigated the therapeutic effect of intranasal insulin on Aβ oligomer (AβO)-induced memory impairment in male rats using the Morris water maze task. Then, molecular and histological changes in response to AβO and/or insulin time course were assessed in the extracted hippocampi on days 1, 14, and 21 of the study using congo red staining, western blot and quantitative real-time PCR analyses. We observed memory impairment, Aβ aggregation, tau hyper-phosphorylation, neuroinflammation, insulin signaling dys-regulation, and down-regulation of miR-26a, miR-124, miR-29a, miR-181b, miR-125b, miR-132, and miR-146a in the hippocampus of AβO-exposed rats 21 days after AβO injection. Intranasal insulin treatment ameliorated memory impairment and concomitantly increased miR-132, miR-181b, and miR-125b expression, attenuated tau phosphorylation levels, Aβ aggregation, and neuroinflammation, and regulated the insulin signaling as well. In conclusion, our study suggest that the neuroprotective effects of insulin on memory observed in AD-like rats could be partially due to the restoration of miR-132, miR-181b, and miR-125b expression in the brain.
大量证据表明,AD 大脑中 miR-132-3p、miR-181b-5p、miR-125b-5p、miR-26a-5p、miR-124-3p、miR-146a-5p、miR-29a-3p 和 miR-30a-5p 的表达失衡与淀粉样β (Aβ) 聚集、tau 病理学、神经炎症和突触功能障碍有关,这些是阿尔茨海默病的主要病理特征。几项研究报道,鼻内给予胰岛素可改善 AD 患者和动物模型的记忆。然而,其潜在的分子机制尚不完全清楚。因此,本研究旨在确定胰岛素是否参与调节与 AD 相关的 microRNAs 的表达。为了实现这一目标,我们首先使用 Morris 水迷宫任务研究了鼻内胰岛素对 Aβ 寡聚体 (AβO) 诱导的雄性大鼠记忆损伤的治疗作用。然后,在研究的第 1、14 和 21 天,通过考马斯亮蓝染色、western blot 和定量实时 PCR 分析,评估了海马中 AβO 和/或胰岛素时间过程的分子和组织学变化。我们观察到,在 AβO 注射 21 天后,AβO 暴露的大鼠海马中出现记忆损伤、Aβ 聚集、tau 过度磷酸化、神经炎症、胰岛素信号转导失调以及 miR-26a、miR-124、miR-29a、miR-181b、miR-125b、miR-132 和 miR-146a 的表达下调。鼻内胰岛素治疗改善了记忆损伤,同时增加了 miR-132、miR-181b 和 miR-125b 的表达,减弱了 tau 磷酸化水平、Aβ 聚集和神经炎症,并调节了胰岛素信号。总之,我们的研究表明,在 AD 样大鼠中观察到的胰岛素对记忆的神经保护作用可能部分归因于大脑中 miR-132、miR-181b 和 miR-125b 表达的恢复。